BMI‐1 protein expression as a negative independent prognostic factor in DLBCL
Sign Up to like & getrecommendations! Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2439_23
Abstract: Meier survival curve analyses with log‐rank test, univariate and multivariate Cox regression model analyses of overall survival (OS), and progression‐free survival (PFS) were performed. Gene ontology (GO) and kyoto encyclopedia of genes and genomes (KEGG)… read more here.
Keywords: dlbcl; melk dlbcl; dlbcl patients; independent prognostic ... See more keywords
Impact of diffuse large B-cell lymphoma on visits to different provider specialties among elderly Medicare beneficiaries: challenges for care coordination.
Sign Up to like & getrecommendations! Published in 2018 at "Translational behavioral medicine"
DOI: 10.1093/tbm/ibx071
Abstract: Newly diagnosed diffuse large B-cell lymphoma (DLBCL) can pose significant challenges to care coordination. We utilized a social-ecological model to understand the impact of DLBCL diagnosis on visits to primary care providers (PCPs) and specialists,… read more here.
Keywords: care coordination; coordination; dlbcl patients; treatment ... See more keywords
Screening of Adverse Prognostic Factors and Construction of Prognostic Index in Previously Untreated Concurrent Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
Sign Up to like & getrecommendations! Published in 2022 at "BioMed Research International"
DOI: 10.1155/2022/4379556
Abstract: Objective Concurrent follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) (defined as FL/DLBCL) have been considered an important pathological feature in cell lymphoma. However, clinicopathological information and prognostic factors in these cases are scarce.… read more here.
Keywords: index; cell; dlbcl patients; lymphoma ... See more keywords
A Single Center Retrospective Study of Real World Relapsed/Refractory DLBCL Patients Eligible for CAR T-Cell Therapy: Patient Characteristics and Outcomes
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-117780
Abstract: Introduction: Patients with Diffuse large B-cell lymphoma (DLBCL) may experience excellent long-term outcomes after initial anthracycline containing therapy. However, patients with relapsed or refractory (R/R) DLBCL often have poor outcomes. Select R/R DLBCL patients may… read more here.
Keywords: dlbcl patients; speakers bureau; therapy; cell ... See more keywords
Infused Autograft-Absolute Lymphocyte Count Predicts Superior Survival in Diffuse Large B-Cell Lymphoma Patients Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation: A Matched-Control Study
Sign Up to like & getrecommendations! Published in 2020 at "Blood"
DOI: 10.1182/blood-2020-133854
Abstract: Introduction Day 15 absolute lymphocyte count (ALC-15) recovery after autologous peripheral blood hematopoietic stem cell transplantation (APBHSCT) is recognized as a prognostic factor for survival. ALC-15 recovery is directly dependent on the amount of collected… read more here.
Keywords: control; dlbcl patients; alc 109; 109 cells ... See more keywords
A simplified frailty score predicts survival and can aid treatment intensity decisions in older DLBCL patients.
Sign Up to like & getrecommendations! Published in 2021 at "Blood advances"
DOI: 10.1182/bloodadvances.2021004777
Abstract: Diffuse large B-cell lymphoma (DLBCL) patients have a median age of 70 years. Yet, empirical knowledge on treatment for older patients is limited as they are frequently excluded from clinical trials. We aimed to construct… read more here.
Keywords: treatment; dlbcl patients; frailty score; frailty ... See more keywords
Expression and Prognostic Value of Glucose Transporter 3 in Diffuse Large B Cell Lymphoma
Sign Up to like & getrecommendations! Published in 2022 at "OncoTargets and therapy"
DOI: 10.2147/ott.s338826
Abstract: Background Several reports have suggested that glucose transporter 3 (GLUT-3) promotes tumor metastasis. The aim of this study was to examine the relationship between the expression level of GLUT-3 and the prognosis of patients with… read more here.
Keywords: glut expression; cell; dlbcl patients; expression ... See more keywords
18F-FDG PET Maximum-Intensity Projections and Artificial Intelligence: A Win-Win Combination to Easily Measure Prognostic Biomarkers in DLBCL Patients
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Nuclear Medicine"
DOI: 10.2967/jnumed.121.263501
Abstract: Visual Abstract Total metabolic tumor volume (TMTV) and tumor dissemination (Dmax) calculated from baseline 18F-FDG PET/CT images are prognostic biomarkers in diffuse large B-cell lymphoma (DLBCL) patients. Yet, their automated calculation remains challenging. The purpose… read more here.
Keywords: dlbcl patients; prognostic biomarkers; tmtv; fdg pet ... See more keywords
Towards genomic-based prognostication and precision therapy for diffuse large B-cell lymphoma
Sign Up to like & getrecommendations! Published in 2020 at "Haematologica"
DOI: 10.3324/haematol.2020.255448
Abstract: large B-cell lymphoma (DLBCL) is complicated by its great clinical and molecular heterogeneity. Twenty years ago, two distinct cell-of-origin (COO) subtypes were identified based on distinct gene expression profiles that reflect different stages of B-cell… read more here.
Keywords: gcb; dlbcl; dlbcl patients; bcl2 ... See more keywords
Hypoxia-related tumor environment correlated with immune infiltration and therapeutic sensitivity in diffuse large B-cell lymphoma
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Genetics"
DOI: 10.3389/fgene.2022.1037716
Abstract: Background: Due to the high heterogeneity of diffuse large B-cell lymphoma (DLBCL), traditional chemotherapy treatment ultimately failed in one-third of the patients. Big challenges existed in finding how to accurately predict prognosis and provide individualized… read more here.
Keywords: dlbcl patients; hypoxia; risk; diffuse large ... See more keywords
Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years
Sign Up to like & getrecommendations! Published in 2021 at "Cancers"
DOI: 10.3390/cancers13184503
Abstract: Simple Summary Cachexia is a major cause of mortality in cancer patients and is characterized by a continuous skeletal muscle loss. Muscle depletion assessed by computed tomography (CT) is a predictive marker in solid tumors… read more here.
Keywords: dlbcl patients; muscle; muscular hypodensity; mortality ... See more keywords